Tech Company Financing Transactions

Ten63 Therapeutics Funding Round

Hatteras Venture Partners, Alexandria Venture Investments and Draper Associates participated in a $15.9 million Series A capital raise for Ten63 Therapeutics. The financing round was announced on 6/15/2023.

Transaction Overview

Company Name
Ten63 Therapeutics
Announced On
6/15/2023
Transaction Type
Venture Equity
Amount
$15,900,000
Round
Series A
Investors

Hatteras Venture Partners (Lead Investor) (Clay Thorp)

Alexandria Venture Investments

Draper Associates

Morpheus Ventures

Sigma Group

SOSV

Proceeds Purpose
The company intends to use the funds to advance and expand its internal pipeline of first-in-class small molecules inhibiting high-impact cancer targets, including continued progression of its lead Myc inhibitor program.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Durham Fwy
Durham, NC Undisclosed
USA
Phone
Undisclosed
Website
www.ten63tx.com
Email Address
[email protected]
Overview
Ten63 is pushing the boundaries of computational drug discovery to design first and best-in-class therapeutics with enhanced durability against previously undruggable targets. Our BEYOND platform allow us to design potent chemistry against the hardest targets by searching previously unexplored, drug-like, synthetically accessible chemical space.
Profile
Ten63 Therapeutics LinkedIn Company Profile
Social Media
Ten63 Therapeutics Company Twitter Account
Company News
Ten63 Therapeutics News
Facebook
Ten63 Therapeutics on Facebook
YouTube
Ten63 Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Bruce Donald
  Bruce Donald LinkedIn Profile  Bruce Donald Twitter Account  Bruce Donald News  Bruce Donald on Facebook
Chief Executive Officer
Marcel Frenkel
  Marcel Frenkel LinkedIn Profile  Marcel Frenkel Twitter Account  Marcel Frenkel News  Marcel Frenkel on Facebook
Chief Technical Officer
Mark Hallen
  Mark Hallen LinkedIn Profile  Mark Hallen Twitter Account  Mark Hallen News  Mark Hallen on Facebook
Co-Founder
Nancy Rich
  Nancy Rich LinkedIn Profile  Nancy Rich Twitter Account  Nancy Rich News  Nancy Rich on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/15/2023: Deepchecks venture capital transaction
Next: 6/15/2023: The Wound Company venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. VC transactions on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.